These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2657275)

  • 1. In vitro/in vivo functionality of Catapres-TTS.
    Enscore DJ; Osborne JL; Shaw JE
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):173-8. PubMed ID: 2657275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
    Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
    Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
    Lewis GR
    N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A community-based trial of transdermal antihypertensive therapy with clonidine (Catapres-TTS).
    Kellaway GS; Lubbe WF
    N Z Med J; 1986 Sep; 99(810):711-4. PubMed ID: 3547202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transdermal therapy of arterial hypertension: a new approach in the management of hypertensive patients].
    Ambrosioni E
    Ann Ital Med Int; 1994 Oct; 9 Suppl():54S-57S. PubMed ID: 7857759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance].
    Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1841-5. PubMed ID: 6676936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects.
    Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonidine through the skin in the treatment of essential hypertension: is it practical?
    Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
    J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient acceptance of transdermal clonidine. A retrospective review of 25 patients.
    Chen SW; Vidt DG
    Cleve Clin J Med; 1989; 56(1):21-6. PubMed ID: 2731324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine.
    Arndts D; Arndts K
    Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal drug delivery: a review of pharmaceutics, pharmacokinetics, and pharmacodynamics.
    Moore L; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1988; 4(4):285-349. PubMed ID: 3133121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypertension by a new transdermal form of clonidine.
    Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
    J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal therapeutic systems and rate controlled drug delivery.
    Yum SI
    Med Prog Technol; 1989; 15(1-2):47-52. PubMed ID: 2530425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
    Frishman WH; Sherman D; Feinfeld DA
    Cardiol Clin; 1987 Nov; 5(4):703-16. PubMed ID: 3331321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oral sustained release clonidine in humans.
    MacGregor TR; Relihan GL; Keirns JJ
    Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of transdermal clonidine in chronic hemodialysis patients.
    Rosansky SJ; Johnson KL; McConnell J
    Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of clonidine.
    Lowenthal DT; Matzek KM; MacGregor TR
    Clin Pharmacokinet; 1988 May; 14(5):287-310. PubMed ID: 3293868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Langley MS; Heel RC
    Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate and extent of absorption of clonidine from a transdermal therapeutic system.
    Toon S; Hopkins KJ; Aarons L; Rowland M
    J Pharm Pharmacol; 1989 Jan; 41(1):17-21. PubMed ID: 2565958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.